Planet Fitness, Inc. (PLNT - Free Report) operates over 1600 fitness clubs in the United States. Because it is solely a domestic play, it isn’t subject to the tariff or trade war issues facing other growth companies like those in technology. Shares are still up 54% year-to-date and got a boost after the third quarter earnings report where it beat the estimate again. This is a growth play, as the stock has a forward P/E of 44. Planet Fitness is currently a Zacks Rank #3 (Hold).

JP Morgan Chase & Co. (JPM - Free Report) is one of the largest banks in the United States. The big banks are cheap. JP Morgan trades with a forward P/E of only 11.9. It’s not surprising that Warren Buffett’s Berkshire Hathaway bought the stock in the third quarter. Earnings are expected to rise 35% in 2018 and another 9% in 2019. JP Morgan is a Zacks Rank #2 (Buy).

Should these two companies be on your investing short list? Find out in this week’s video.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>